-
REGENXBIO WEBINAR
AFFINITY DUCHENNE®: New Phase 1/2 Interim Functional Data Watch HERE The post REGENXBIO WEBINAR appeared
-
Our family’s all-star football player also lives with Duchenne
I’m a mother of seven and a caregiver to the three of my sons who
-
PPMD Announces Children’s Hospital of Philadelphia as CDCC, Recipient of Inaugural Clinical Research Designation
PPMD is pleased to announce the expansion of its renowned Certified Duchenne Care Center (CDCC)
-
Duvyzat conditionally approved by EC to treat Duchenne MD
The European Comission has conditionally approved Duvyzat (givinostat) to be taken alongside corticosteroids for treating
-
Capricor’s Advisory Committee meeting with FDA to be held July 30, 2025
Capricor Therapeutics, which received early funding from CureDuchenne, announced regulatory updates for their Deramiocel program
-
After incredible hardships, I still feel blessed
I’m between two anniversaries. Today is the 36th anniversary of the collision I had with
-
Viral vector in LGMD2E gene therapy gets new FDA designation
The U.S. Food and Drug Administration (FDA) granted platform technology designation to the viral vector
-
The Joys (and Lessons) of Fatherhood from MDA Ambassadors
As every father knows, parenthood is an incredible journey filled with joy, challenges, victories, growth,
-
-
Watch: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne (Webinar Recording)
Dyne Therapeutics recently joined PPMD for a community webinar on the DELIVER clinical trial evaluating
